DNTH logo

Dianthus Therapeutics, Inc. (DNTH) Cash From Operations

Annual CFO:

-$78.18M-$41.32M(-112.09%)
December 31, 2024

Summary

  • As of today, DNTH annual cash from operations is -$78.18 million, with the most recent change of -$41.32 million (-112.09%) on December 31, 2024.
  • During the last 3 years, DNTH annual cash from operations has fallen by -$18.65 million (-31.33%).
  • DNTH annual cash from operations is now -1097.43% below its all-time high of -$6.53 million, reached on December 1, 2016.

Performance

DNTH Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

Quarterly CFO:

-$23.89M+$3.74M(+13.53%)
June 30, 2025

Summary

  • As of today, DNTH quarterly cash from operations is -$23.89 million, with the most recent change of +$3.74 million (+13.53%) on June 30, 2025.
  • Over the past year, DNTH quarterly cash from operations has dropped by -$9.36 million (-64.45%).
  • DNTH quarterly cash from operations is now -245.91% below its all-time high of $16.38 million, reached on September 30, 2022.

Performance

DNTH Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

TTM CFO:

-$100.23M-$9.36M(-10.30%)
June 30, 2025

Summary

  • As of today, DNTH TTM cash from operations is -$100.23 million, with the most recent change of -$9.36 million (-10.30%) on June 30, 2025.
  • Over the past year, DNTH TTM cash from operations has dropped by -$48.92 million (-95.33%).
  • DNTH TTM cash from operations is now -2387.17% below its all-time high of -$4.03 million, reached on March 1, 2017.

Performance

DNTH TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

DNTH Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-112.1%-64.5%-95.3%
3Y3 Years-31.3%-41.8%-51.1%
5Y5 Years-36.9%-24.4%-52.1%

DNTH Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-168.9%at low-245.9%+13.5%-1238.0%at low
5Y5-Year-168.9%at low-245.9%+13.5%-1238.0%at low
All-TimeAll-Time-1097.4%at low-245.9%+13.5%-2387.2%at low

DNTH Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$23.89M(+13.5%)
-$100.23M(-10.3%)
Mar 2025
-
-$27.63M(-0.7%)
-$90.87M(-16.2%)
Dec 2024
-$78.18M(-112.1%)
-$27.44M(-29.0%)
-$78.18M(-24.9%)
Sep 2024
-
-$21.27M(-46.4%)
-$62.59M(-22.0%)
Jun 2024
-
-$14.53M(+2.8%)
-$51.31M(-23.6%)
Mar 2024
-
-$14.94M(-26.0%)
-$41.52M(-12.6%)
Dec 2023
-$36.86M(-26.8%)
-$11.85M(-18.6%)
-$36.86M(-8.9%)
Sep 2023
-
-$9.99M(-111.2%)
-$33.86M(-352.0%)
Jun 2023
-
-$4.73M(+54.0%)
-$7.49M(+61.8%)
Mar 2023
-
-$10.28M(-16.2%)
-$19.61M(+32.5%)
Dec 2022
-$29.07M(+51.2%)
-$8.85M(-154.1%)
-$29.07M(+19.0%)
Sep 2022
-
$16.38M(+197.2%)
-$35.91M(+45.9%)
Jun 2022
-
-$16.85M(+14.6%)
-$66.35M(-6.2%)
Mar 2022
-
-$19.74M(-25.8%)
-$62.50M(-5.0%)
Dec 2021
-$59.53M
-
-
Dec 2021
-
-$15.69M(-11.5%)
-$59.53M(-3.4%)
Sep 2021
-
-$14.07M(-8.2%)
-$57.57M(+0.6%)
Jun 2021
-
-$13.00M(+22.5%)
-$57.94M(+9.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$16.77M(-22.1%)
-$64.14M(-0.2%)
Dec 2020
-$64.02M(-12.1%)
-$13.73M(+4.8%)
-$64.02M(+2.9%)
Sep 2020
-
-$14.43M(+24.9%)
-$65.92M(-4.6%)
Jun 2020
-
-$19.20M(-15.3%)
-$63.00M(-7.1%)
Mar 2020
-
-$16.66M(-6.6%)
-$58.82M(-3.0%)
Dec 2019
-$57.10M(-36.3%)
-$15.63M(-35.8%)
-$57.10M(-5.6%)
Sep 2019
-
-$11.51M(+23.5%)
-$54.10M(-1.8%)
Jun 2019
-
-$15.03M(-0.6%)
-$53.14M(-12.5%)
Mar 2019
-
-$14.94M(-18.3%)
-$47.22M(-12.7%)
Dec 2018
-$41.89M(-88.1%)
-$12.62M(-19.7%)
-$41.89M(-43.1%)
Sep 2018
-
-$10.55M(-15.8%)
-$29.26M(-21.1%)
Jun 2018
-
-$9.11M(+5.2%)
-$24.16M(-23.2%)
Mar 2018
-
-$9.60M(-76.4%)
-$19.61M(-39.7%)
Dec 2017
-$22.26M(-241.0%)
-
-
Sep 2017
-
-$5.44M(-19.4%)
-$14.03M(-63.4%)
Jun 2017
-
-$4.56M(-13.1%)
-$8.59M(-113.1%)
Mar 2017
-
-$4.03M
-$4.03M
Dec 2016
-$6.53M
-
-

FAQ

  • What is Dianthus Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is Dianthus Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. quarterly cash from operations year-on-year change?
  • What is Dianthus Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. TTM cash from operations year-on-year change?

What is Dianthus Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of DNTH is -$78.18M

What is the all-time high annual cash from operations for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high annual cash from operations is -$6.53M

What is Dianthus Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, DNTH annual cash from operations has changed by -$41.32M (-112.09%)

What is Dianthus Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of DNTH is -$23.89M

What is the all-time high quarterly cash from operations for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high quarterly cash from operations is $16.38M

What is Dianthus Therapeutics, Inc. quarterly cash from operations year-on-year change?

Over the past year, DNTH quarterly cash from operations has changed by -$9.36M (-64.45%)

What is Dianthus Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of DNTH is -$100.23M

What is the all-time high TTM cash from operations for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high TTM cash from operations is -$4.03M

What is Dianthus Therapeutics, Inc. TTM cash from operations year-on-year change?

Over the past year, DNTH TTM cash from operations has changed by -$48.92M (-95.33%)
On this page